ConductScience.org, home

Paper7513620

V79 Chinese hamster lung cells resistant to the bis-alkylator bizelesin are multidrug-resistant.

Butryn RK and 6 others. Cancer Chemother Pharmacol, 1994. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. V79 Chinese hamster lung cells resistant to the bis-alkylator bizelesin are multidrug-resistant. Papers, record 7513620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7513620

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
V79 Chinese hamster lung cells resistant to the bis-alkylator bizelesin are multidrug-resistant.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1994
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2019-12-10
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Butryn RKR K
2Smith KSK S
3Adams EGE G
4Abraham II
5Stackpole JJ
6Sampson KEK E
7Bhuyan BKB K

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
IndolesMajor topic
LungMajor topic
UreaMajor topic
Alkylating Agents
Animals
Blotting, Northern
Cell Division
Cell Line
Cell Survival
Cricetinae
Cricetulus
Drug Resistance
Duocarmycins
Fibroblasts
Genotype
Humans
Mice
Phenotype
RNA
Tumor Cells, Cultured
Verapamil

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13457471Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.Science1986https://conductscience.org/library/papers/3457471PubMed
21394193Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cells.Cancer Res1992https://conductscience.org/library/papers/1394193PubMed
32863759Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines.Nature1985https://conductscience.org/library/papers/2863759PubMed
46326095Genomic sequencing.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6326095PubMed
56698888Preliminary toxicity studies with the DNA-binding antibiotic, CC-1065.J Antibiot (Tokyo)1984https://conductscience.org/library/papers/6698888PubMed
62145026P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.Br J Cancer1990https://conductscience.org/library/papers/2145026PubMed
72208103Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy--a review.Cancer Res1990https://conductscience.org/library/papers/2208103PubMed
8709555In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.Cancer Treat Rep1978https://conductscience.org/library/papers/709555PubMed
92898143A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2898143PubMed
106312838A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.Anal Biochem1983https://conductscience.org/library/papers/6312838PubMed
111971796Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase causes increased drug sensitivity and decreased expression of P-glycoprotein.Exp Cell Res1990https://conductscience.org/library/papers/1971796PubMed
128443816Multidrug resistance is a component of V79 cell resistance to the alkylating agent adozelesin.Cancer Res1993https://conductscience.org/library/papers/8443816PubMed
136354439Establishment of cross-resistance profiles for new agents.Cancer Treat Rep1983https://conductscience.org/library/papers/6354439PubMed
143460695Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.Cancer Res1986https://conductscience.org/library/papers/3460695PubMed
157105029CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival.Cancer Res1982https://conductscience.org/library/papers/7105029PubMed
164040369Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.Biochem Pharmacol1985https://conductscience.org/library/papers/4040369PubMed
173731096Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.Cancer Res1986https://conductscience.org/library/papers/3731096PubMed
184855907Reduced permeability in CHO cells as a mechanism of resistance to colchicine.J Cell Physiol1974https://conductscience.org/library/papers/4855907PubMed
197083173Mechanism of interaction of CC-1065 (NSC 298223) with DNA.Cancer Res1982https://conductscience.org/library/papers/7083173PubMed
206135505Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein.Cancer Res1983https://conductscience.org/library/papers/6135505PubMed

See all 27 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
39409913A Comprehensive Review of the Antitumor Properties and Mechanistic Insights of Duocarmycin Analogs.Cancers (Basel)2024https://conductscience.org/library/papers/39409913PubMed
36145664Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates.Pharmaceutics2022https://conductscience.org/library/papers/36145664PubMed
25383306PVP-coated, negatively charged silver nanoparticles: A multi-center study of their physicochemical characteristics, cell culture and in vivo experiments.Beilstein J Nanotechnol2014https://conductscience.org/library/papers/25383306PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7513620

GET https://conductscience.org/api/papers/v1/7513620/references?page=2